Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Pfizer Inc., GlaxoSmithKline PLC, Allergan PLC and Eli Lilly & Co. are among big pharma firms facing generic competition to blockbuster brands, while AbbVie Inc. and Roche have got biosimilar rivals to worry about.
New drug launches have increased over the past couple of years, but few have reached blockbuster status yet. Meanwhile, China’s increasing appetite (and willingness to pay) for therapeutic innovation was a positive for several big pharma companies in the first quarter. Scrip’s webinar takes a deep dive into the key issues and trends emerging from industry earnings calls.
Scrip: industry news and insights
By Joseph Haas
The companies are combining their technologies to seek neutralizing antibody therapeutics that could prevent or treat COVID-19, building on their previous partnership in monitoring minimal residual disease in blood cancers.
Topics Coronavirus
Scrip: industry news and insights
Fears over shortages of drugs needed for ventilated patients rise, while Merck & Co, Pfizer and Lilly allow their medics to volunteer, and attention turns to beta-interferon products and NK cell therapies to fight the virus.
Topics Coronavirus
Scrip: industry news and insights
By Kevin Grogan 02 Apr 2020
The Belgian biotech has managed to attract considerable sums from venture capitalists over the past couple of years amid hopes...
Request a Trial
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Support the development and validation of your strategic plans and ensure commercial decisions are based on marketplace realities. Datamonitor Healthcare offers expert coverage of key diseases, treatments, companies, drugs, market access and market trends. Our primary research with physicians, payers, and KOLs (key opinion leaders) informs our treatment standards data and patient-based forecasts.
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Biomedtracker, Strategic Transactions, and Medtrack have been combined into a single commercial intelligence solution, enabling you to make the most informed decisions to develop successful commercial strategies. Track and understand the impacts of market events for the companies, diseases, products, and targets you care about.
Looking for more products Product Finder
